| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/07/2005 | US20050074452 Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| 04/07/2005 | US20050074434 Remedies for metabolic bone diseases |
| 04/07/2005 | US20050074427 IL-17 like molecules and uses thereof |
| 04/07/2005 | US20050074401 Selective targeting of tumor vasculature using radiolabelled antibody molecules |
| 04/07/2005 | US20050073511 Display for sharing display data channel |
| 04/07/2005 | DE10341812A1 Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung Differentially expressed in tumors gene products and their use |
| 04/07/2005 | CA2814269A1 Identification of tumour-associated cell surface antigens for diagnosis and therapy |
| 04/07/2005 | CA2540701A1 Proteins expressed in nk cells |
| 04/07/2005 | CA2540177A1 Seneca valley virus based compositions and methods for treating disease |
| 04/07/2005 | CA2539837A1 Identification of tumour-associated cell surface antigens for diagnosis and therapy |
| 04/07/2005 | CA2539716A1 Compositions and methods to accelerate hematologic recovery |
| 04/07/2005 | CA2539432A1 Altering a b cell pathology using self-derived antigens in conjunction with specific-binding cytoreductive agent |
| 04/07/2005 | CA2538852A1 Fragment complementation assays for g-protein-coupled receptors and their signaling pathways |
| 04/07/2005 | CA2538737A1 Treatment of respiratory diseases with anti-il-2 receptor antibodies |
| 04/07/2005 | CA2537876A1 Antibodies to m-csf |
| 04/06/2005 | EP1520860A2 Recombinant protein PilC, method for its production and use thereof |
| 04/06/2005 | EP1520588A2 Uses of antibodies to aminophospholipids for cancer treatment |
| 04/06/2005 | EP1519960A2 Mutant fab fragments of the chimeric 13b8.2 anti-cd4 antibody and uses thereof |
| 04/06/2005 | EP1519959A2 Anti-cd20 antibodies and fusion proteins thereof and methods of use |
| 04/06/2005 | EP1519958A2 Humanized monoclonal antibody hpam4 |
| 04/06/2005 | EP1519956A2 Epha2 monoclonal antibodies and methods of use thereof |
| 04/06/2005 | EP1519942A2 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 04/06/2005 | EP1519749A1 Chemotactic factor inhibitor for modulating inflammatory reactions |
| 04/06/2005 | EP1519748A1 Microparticle with cd28-specific monoclonal antibodies |
| 04/06/2005 | EP1519747A2 Human monoclonal antibodies to prostate specific membrane antigen (psma) |
| 04/06/2005 | EP1519746A1 Use of digoxin immune fab for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients |
| 04/06/2005 | EP1519742A2 Osteoclast-associated receptor |
| 04/06/2005 | EP1519740A2 Rapid improvement of cognition in conditions related to a-beta |
| 04/06/2005 | EP1360282B1 Method for inactivation of TSE |
| 04/06/2005 | EP1284997B1 Therapeutic compounds for ovarian cancer |
| 04/06/2005 | EP1212100B1 Delivery system for antidandruff agent |
| 04/06/2005 | EP1162993B1 Use of casb616 polypeptides and polynucleotides for cancer treatment |
| 04/06/2005 | EP1101118B1 Immunological determination of the hydrophobic pulmonary surfactant protein SP-C |
| 04/06/2005 | EP1100529B1 Thymosin beta 4 promotes wound repair |
| 04/06/2005 | EP1040190B1 Serine proteinase inhibitors |
| 04/06/2005 | EP1002093B1 Preparation and use of recombinant influenza a virus m2 constructs and vaccines |
| 04/06/2005 | EP0824594B1 Improved methods for transfecting t cells |
| 04/06/2005 | EP0748219B1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/06/2005 | EP0553244B2 Targeted immunostimulation with bispecific reagents |
| 04/06/2005 | CN1604966A Direct targeting binding proteins |
| 04/06/2005 | CN1604964A Ashbya gossypii enzymes |
| 04/06/2005 | CN1604910A Affinity enhancement agents |
| 04/06/2005 | CN1604792A Agents for enhancing the immune response |
| 04/06/2005 | CN1603345A Trivalent bispecific antibody and its preparation process and use |
| 04/06/2005 | CN1603342A Caspase-8 interacting proteins |
| 04/06/2005 | CN1603341A Human calcium ion / calmodulin deopendent protein kinase II inhibitory protein alpha, its coded sequence and use |
| 04/06/2005 | CN1195869C Monoclonal antibody, hybridoma, immunoassay method and diagnosis kit |
| 04/06/2005 | CN1195853C Neurotrophic factor NNT-1 |
| 04/06/2005 | CN1195849C APPIL-a novel protein with growth effects |
| 04/06/2005 | CN1195779C Double-specificity antibody resisting human ovary cancer and human CD3 |
| 04/06/2005 | CN1195774C HEV antigenic peptide and its method |
| 04/06/2005 | CN1195551C Novel agent for controlling cell activity |
| 04/06/2005 | CN1195546C Application of monoclone antibody combined with CD154 for inhibiting rejection of insulin generating transplanted tissue |
| 04/05/2005 | US6875848 Process for the production of virus-inactivated human gammaglobulin G |
| 04/05/2005 | US6875845 Polypeptide for use in the treatment of cancer |
| 04/05/2005 | US6875749 Methods of facilitating vascular growth |
| 04/05/2005 | US6875599 Enzymatic protein for use in the treatment of inflammation, cancers, cardiovascular, brain, respiratory and crohn's disease |
| 04/05/2005 | US6875597 Comprises nucleotide sequences coding sulfotransferase for identifying modulators and designing drug delivery systems |
| 04/05/2005 | US6875590 Nucleotide sequences coding polypeptide for use as tools in genetic engineering |
| 04/05/2005 | US6875580 Hybridoma cell line which produces monoclonal antibody for isolation and identification of a subset of antigen presenting cells; immunostaining and immunohistochemistry |
| 04/05/2005 | US6875570 Proteins and nucleic acids encoding same |
| 04/05/2005 | US6875459 Method and apparatus for separation of milk, colostrum, and whey |
| 04/05/2005 | US6875434 Methods of treatment of Alzheimer's disease |
| 04/05/2005 | US6875433 Heavy chain variable region peptides coded by DNA sequences, used as vaccines for prevention and diagnosis of viral diseases |
| 04/05/2005 | CA2348898C Murine expression of human ig.lambda. locus |
| 04/05/2005 | CA2232344C Compositions and methods for enhancing immune responses mediated by antigen-presenting cells |
| 04/05/2005 | CA2203540C Major outer membrane protein cd of moraxella |
| 04/05/2005 | CA2161798C Animal model for hepatitis virus infection |
| 04/05/2005 | CA1341478C Therapeutic methods using catalytic antibodies |
| 04/03/2005 | CA2480616A1 Specific markers for diabetes |
| 03/31/2005 | WO2005029082A2 Methods for the in vitro diagnosis and in vitro prognosis of cancer of the pancreas and for the development of drugs against cancer of the pancreas and/or pancreatitis |
| 03/31/2005 | WO2005029066A2 Diagnostic markers and pharmacological targets in heart failure and related reagents and methods of use thereof |
| 03/31/2005 | WO2005028673A1 A method for detecting nipah virus and method for providing immunoprotection against henipaviruses |
| 03/31/2005 | WO2005028667A1 Drug targeting g protein-coupled receptor expressed in human mast cells and method of screening the same |
| 03/31/2005 | WO2005028653A1 Method for neutralizing effects of secreted pla2 iia |
| 03/31/2005 | WO2005028515A1 Recombinant antibody against human insulin-like growth factor |
| 03/31/2005 | WO2005028514A1 Use of a compound for reducing the biological effectiveness of il-6 |
| 03/31/2005 | WO2005028513A2 High-yield method for the production of human antibodies blocking the biological activity of a human cytokine |
| 03/31/2005 | WO2005028512A1 Pro-inflammatory and anti-inflammatory antibodies against the heparin-binding protein (hbp) |
| 03/31/2005 | WO2005028511A2 Anti-amyloid antibodies, compositions, methods and uses |
| 03/31/2005 | WO2005028510A2 Methods, kits, and compositions for the development and use of monoclonal antibodies specific to antigens of low immunogenicity |
| 03/31/2005 | WO2005028509A1 Tlr2 antagonistic antibody and use thereof |
| 03/31/2005 | WO2005028508A2 Nogo-a binding with enhanced affinity and pharmaceutical use thereof |
| 03/31/2005 | WO2005028507A1 CRYSTAL STRUCTURE OF CD3ϵϜ/OKT3 COMPLEX |
| 03/31/2005 | WO2005028503A1 Peptide originating in hepatitis c virus |
| 03/31/2005 | WO2005028499A2 Peptide that binds to a broadly neutralizing anti-hiv antibody-structure of 4e10 fab fragment complex, uses thereof, compositions therefrom |
| 03/31/2005 | WO2005028498A2 Kid3 and kid3 antibodies that bind thereto |
| 03/31/2005 | WO2005028497A2 Receptor binding peptides derived from the sars s protein |
| 03/31/2005 | WO2005028433A2 CRIPTO ANTAGONISM OF ACTIVIN AND TGF-β SIGNALING |
| 03/31/2005 | WO2005027966A2 Antibodies with altered effector functions |
| 03/31/2005 | WO2005027965A1 Antibodies against annexins, use thereof for therapy and diagnosis. use of annexins for therapy and diagnosis. |
| 03/31/2005 | WO2005027964A1 Measles subunit vaccine |
| 03/31/2005 | WO2005027963A2 METHODS AND COMPOSITIONS FOR THE GENERATION OF A PROTECTIVE IMMUNE RESPONSE AGAINTS SARS-CoV |
| 03/31/2005 | WO2005027871A2 Method for production of bioresorbable microparticles microparticles thus obtained and use thereof |
| 03/31/2005 | WO2005027846A2 Elicitation of antibodies to self peptides in mice by immunization with dendritic cells |
| 03/31/2005 | WO2005027836A2 Immunogen |
| 03/31/2005 | WO2005027831A2 Modulators of p-selectin glycoprotein ligand 1 |
| 03/31/2005 | WO2005019259A3 Variants of interleukin-1 receptor antagonist: compositions and uses thereof |
| 03/31/2005 | WO2005012495A3 Methods for expression and purification of immunotoxins |
| 03/31/2005 | WO2005007800A3 Monoclonal antibody against platelet membrane glycoprotein vi |